About DAYBUE

Maddy, age 20, living with Rett syndrome, with her family

Maddy, age 21,
living with Rett
syndrome
, with
her family

How was DAYBUE studied?

Caregivers and doctors evaluated changes in the signs and symptoms of Rett syndrome in the LAVENDER™ study

Because caregivers possess such a deep knowledge of their loved one, they contributed directly to the evaluation of the overall effectiveness of DAYBUE. Doctors evaluated if patients improved or got worse, while caregivers looked for changes in the signs and symptoms of Rett syndrome.

Icon of two hands being held in the shape of a heart

Caregivers used the Rett Syndrome Behaviour Questionnaire (RSBQ) to evaluate changes in the signs and symptoms of Rett syndrome.

Doctor icon

Doctors used the Clinical Global Impression-Improvement (CGI-I) scale to evaluate if Rett symptoms had improved or worsened.

Study comparison icon
Expand to see study design

The effectiveness and safety of DAYBUE were evaluated in the 12-week LAVENDER clinical study of 187 female patients aged 5 to 20 with Rett syndrome

Study results

Caregivers evaluated changes in a range of symptoms using the RSBQ

RSBQ is a behavior questionnaire completed by caregivers to evaluate the range of symptoms of Rett syndrome.

What does the RSBQ measure?

Irregular breathing patterns icon

Breathing

Hand movements or stereotypies icons

Hand movements or stereotypies

Repetitive behaviors icon

Repetitive behaviors

Nighttime behaviors icon

Nighttime behaviors

Vocalizations icon

Vocalizations

Facial expressions icon

Facial expressions

Eye gaze icon

Eye gaze

Mood icon

Mood

Understanding RSBQ

  • Caregivers evaluated 45 items on the RSBQ. Each item was scored as not true (0), somewhat or sometimes true (1), or very true or often true (2)

  • The scores were added up to determine the RSBQ total score across symptoms

  • Researchers looked at the change in average RSBQ total score from the start of the study to measure how DAYBUE impacted the signs and symptoms of Rett at Week 12 when compared to patients receiving placebo

At 12 weeks, caregivers observed:


Significant improvements

in the signs and symptoms of Rett syndrome as measured by average change in RSBQ

total score with DAYBUE vs placebo


  • At 12 weeks, the group of patients receiving DAYBUE (n=76) saw a decrease of 4.9 in average RSBQ total score from the start of the study when compared with a decrease of 1.7 in the placebo group (n=85), meaning an improvement in Rett symptoms

  • The difference between the two groups was -3.2. A lower score meant signs and symptoms of Rett syndrome were less severe

  • Before starting treatment, the average RSBQ total score for the DAYBUE group was 43.7. For the placebo group, the average RSBQ total score before treatment was 44.5

  • Results varied between patients in the clinical study. The effect of DAYBUE on individual symptoms measured by RSBQ has not been shown. Individual results may vary with DAYBUE

What improvements could DAYBUE help spark?

Caregiver’s description of improvements with DAYBUE:

Symptom
areas
(RSBQ)
Quinn, 5 years oldQuinn, 5 years old
Quinn6 years old Taking DAYBUE
since 2021
Clare, 8 years oldClare, 8 years old
Clare9 years old Taking DAYBUE
since 2021
Kate, 9 years oldKate, 9 years old
Kate9 years old Taking DAYBUE
since 2021
Ellie, 15 years oldEllie, 15 years old
Ellie16 years old Taking DAYBUE
since 2020
Maddy, 20 years oldMaddy, 20 years old
Maddy21 years old Taking DAYBUE
since 2020
Hand movements or stereotypies
More control of hands. Can hold objects longer. Not grasping her body and face as much Hands are more fluid and open, can hold a fork or cup, taps on fridge when hungry More purposeful hand use. Able to use a spoon and point at and touch her tablet Quiet, calmer hands. Can hold a cup, fork and grasp and reach for things Less aggressive hand movements. More control of hands
Repetitive behaviors icon
Repetitive behaviors
Teeth grinding much improvedHardly grinds her teeth anymore
Irregular breathing patterns icon
Breathing
Less frequent breath holding and less hyperventilatingFewer “blue spells” (breath holding)
Nighttime behaviors icon
Nighttime behaviors
Less frequent night terrors allow her to sleep better Fewer night terrors and laughing spells - now family gets more sleep
Vocalizations icon
Vocalizations
Increased nonverbal vocalizations, able to let people know when she wants something She makes a lot of chatty sounds. Says “fun, funny, and food“ No words, but makes more sounds to respond
Facial expressions icon
Facial
expressions
Doesn't stick her tongue out as often
Eye gaze icon
Eye gaze
Can hold her gaze to participate and engage, especially in the classroom Uses eye gaze more to convey feelings, needs, and wishes. Allows her to show family what she wants for a snack Able to use her eye-gaze device better to convey wishesUses her eyes to say yes or no and to make choices Makes choices more quickly with her eyes. More of an interest in using her eye-gaze device
Mood icon
Mood
Her moods are more predictable and cries a lot less Less screaming and tantrums. Able to take an interest in the things around her More peaceful at home, in school, and in groups She's able to regulate her emotions a little better. She's happier than she used to be Mood is better, happier, much less crying for no apparent reason
Clare, age 8, living with Rett syndrome, with her momClare, age 8, living with Rett syndrome, with her mom

Learn from caregivers and their individual loved one’s experience with DAYBUE

View DAYBUE stories

Clare, age 9, living with Rett syndrome, with her mom

At 12 weeks, doctors observed:

Checklist icon

Significant improvements in the signs and symptoms of Rett syndrome in patients taking DAYBUE vs placebo

The CGI-I (Clinical Global Impression-Improvement) scale was used by doctors to evaluate improvement or worsening of Rett symptoms.

  • 38% of patients (n=77) had improvement in symptoms with DAYBUE vs 15% of patients (n=86) on placebo

    • Much improved (13% vs 5% for placebo), minimally improved (25% vs 10%)

  • 61% of patients had no improvements in symptoms with DAYBUE vs 81% of patients taking placebo

Important Note: Because each individual with Rett syndrome is unique—with a unique set of symptoms—improvements with DAYBUE may be different for everyone.

Do you have questions about treatment with DAYBUE?


While treatment with DAYBUE is a decision you and your loved one’s doctor can make, Family Support Educators can help answer your questions about Rett syndrome, comprehensive care, and connecting with other caregivers.

Get connected with a Family Support Educator

Lara, Family Support Educator

Understanding the possible GI side effects of DAYBUE

As with any medication, it’s important to talk to your loved one’s doctor about the possibility of side effects with DAYBUE. Not every person will experience the same side effects, and for some people, certain side effects, such as diarrhea and vomiting, may be more severe than others.

Side effects may include:

Diarrhea icon

Diarrhea:

Diarrhea is a common side effect of DAYBUE that can sometimes be severe. Diarrhea may cause your child to lose too much water from their body (dehydration). Before starting treatment with DAYBUE, stop taking laxatives. Tell your doctor if your child has diarrhea while taking DAYBUE. Your doctor may ask you to increase the amount your child drinks or give antidiarrheal medicine as needed.

upset stomach icon

Vomiting:

Vomiting is a common side effect of DAYBUE. Sometimes vomit can get into your child's lungs (aspiration), which could cause an infection (aspiration pneumonia). Tell your doctor if they have severe vomiting or if vomiting happens often.

Scale icon

Weight loss:

DAYBUE can cause weight loss. Tell your doctor if you notice your child is losing weight at any time during treatment with DAYBUE.

Common side effects in the 12-week LAVENDER trialCommon side effects in the 12-week LAVENDER trial

Learn how to help manage possible side effects

Management guidance

Is DAYBUE right for your child?

The DAYBUE Overview Brochure provides information about DAYBUE clinical trial results and safety info

The DAYBUE Overview Brochure provides information about DAYBUE clinical study results, safety facts, caregiver experiences, and helpful treatment tips.

The DAYBUE Starting Treatment Discussion Guide for caregivers, a tool you can use to talk to your child’s doctor about DAYBUE

The DAYBUE Treatment Discussion Guide is a tool you can use to talk to your loved one’s doctor about DAYBUE.


Support by your side

Acadia Connect is a patient and family support program that connects you and your family with educational support and resources throughout the DAYBUE treatment journey.

Call Acadia Connect at 1-844-737-2223, Monday to Friday, 8AM to 8PM ET, to learn more about our individualized support program designed to help meet the needs of your loved one taking DAYBUE.

Learn how we can help